🇺🇸 FDA
Pipeline program

AUTO1

FELIX (AUTO1-AL1)

Phase 2 mab active

Quick answer

AUTO1 for Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia is a Phase 2 program (mab) at Autolus Therapeutics plc with 2 ClinicalTrials.gov record(s).

Program details

Company
Autolus Therapeutics plc
Indication
Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia
Phase
Phase 2
Modality
mab
Status
active

Clinical trials